These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 15947687

  • 1. Urinary uronate and sulfated glycosaminoglycan levels: markers for interstitial cystitis severity.
    Lokeshwar VB, Selzer MG, Cerwinka WH, Gomez MF, Kester RR, Bejany DE, Gousse AE.
    J Urol; 2005 Jul; 174(1):344-9. PubMed ID: 15947687
    [Abstract] [Full Text] [Related]

  • 2. Uronate peaks and urinary hyaluronic acid levels correlate with interstitial cystitis severity.
    Lokeshwar VB, Selzer MG, Unwala DJ, Estrella V, Gomez MF, Golshani R, Kester RR, Klumpp DJ, Gousse AE.
    J Urol; 2006 Sep; 176(3):1001-7. PubMed ID: 16890679
    [Abstract] [Full Text] [Related]

  • 3. The association of elevated urinary total to sulfated glycosaminoglycan ratio and high molecular mass hyaluronic acid with interstitial cystitis.
    Wei DC, Politano VA, Selzer MG, Lokeshwar VB.
    J Urol; 2000 May; 163(5):1577-83. PubMed ID: 10751891
    [Abstract] [Full Text] [Related]

  • 4. Comparison of cetylpyridinium chloride and cetyltrimethylammonium bromide extractive procedures for quantification and characterization of human urinary glycosaminoglycans.
    Buzzega D, Pederzoli F, Maccari F, Aslan D, Türk M, Volpi N.
    Clin Chem Lab Med; 2010 Aug; 48(8):1133-9. PubMed ID: 20441479
    [Abstract] [Full Text] [Related]

  • 5. Urinary chondroitin sulfates, heparan sulfate and total sulfated glycosaminoglycans in interstitial cystitis.
    Erickson DR, Ordille S, Martin A, Bhavanandan VP.
    J Urol; 1997 Jan; 157(1):61-4. PubMed ID: 8976216
    [Abstract] [Full Text] [Related]

  • 6. Urinary glycosaminoglycan excretion as a laboratory marker in the diagnosis of interstitial cystitis.
    Hurst RE, Parsons CL, Roy JB, Young JL.
    J Urol; 1993 Jan; 149(1):31-5. PubMed ID: 8417212
    [Abstract] [Full Text] [Related]

  • 7. Decreased urine glycosaminoglycan excretion in cats with interstitial cystitis.
    Buffington CA, Blaisdell JL, Binns SP, Woodworth BE.
    J Urol; 1996 May; 155(5):1801-4. PubMed ID: 8627887
    [Abstract] [Full Text] [Related]

  • 8. Urine nerve growth factor (NGF) level, bladder nerve staining and symptom/problem scores in patients with interstitial cystitis.
    Tonyali S, Ates D, Akbiyik F, Kankaya D, Baydar D, Ergen A.
    Adv Clin Exp Med; 2018 Feb; 27(2):159-163. PubMed ID: 29521057
    [Abstract] [Full Text] [Related]

  • 9. Decreased urinary uronic acid levels in individuals with interstitial cystitis.
    Parsons CL, Hurst RE.
    J Urol; 1990 Apr; 143(4):690-3. PubMed ID: 2313793
    [Abstract] [Full Text] [Related]

  • 10. Glycosaminoglycans excretion in interstitial cystitis.
    Akçay T, Konukoğlu D.
    Int Urol Nephrol; 1999 Apr; 31(4):431-5. PubMed ID: 10668936
    [Abstract] [Full Text] [Related]

  • 11. [Efficiency of O'Leary-Sant symptom index and problem index in the diagnosis of interstitial cystitis].
    Xu L, Zhang P, Zhang N, Yang Y, Wu ZJ, Zhang CH, Zhang XD.
    Zhonghua Yi Xue Za Zhi; 2013 Nov 12; 93(42):3347-50. PubMed ID: 24418029
    [Abstract] [Full Text] [Related]

  • 12. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment.
    Liu HT, Tyagi P, Chancellor MB, Kuo HC.
    BJU Int; 2009 Nov 12; 104(10):1476-81. PubMed ID: 19522864
    [Abstract] [Full Text] [Related]

  • 13. Increased urinary leukotriene E4 and eosinophil protein X excretion in patients with interstitial cystitis.
    Bouchelouche K, Kristensen B, Nordling J, Horn T, Bouchelouche P.
    J Urol; 2001 Dec 12; 166(6):2121-5. PubMed ID: 11696719
    [Abstract] [Full Text] [Related]

  • 14. Increased urinary hyaluronic acid and interstitial cystitis.
    Erickson DR, Sheykhnazari M, Ordille S, Bhavanandan VP.
    J Urol; 1998 Oct 12; 160(4):1282-4. PubMed ID: 9751336
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the metabolism of glycosaminoglycans in patients with interstitial cystis.
    Lucon M, Martins JR, Leite KR, Soler R, Nader HB, Srougi M, Bruschini H.
    Int Braz J Urol; 2014 Oct 12; 40(1):72-9. PubMed ID: 24642152
    [Abstract] [Full Text] [Related]

  • 16. Prevalence and impact of bacteriuria and/or urinary tract infection in interstitial cystitis/painful bladder syndrome.
    Nickel JC, Shoskes DA, Irvine-Bird K.
    Urology; 2010 Oct 12; 76(4):799-803. PubMed ID: 20573386
    [Abstract] [Full Text] [Related]

  • 17. Urinary glycosaminoglycans excretion and the effect of dimethyl sulfoxide in an experimental model of non-bacterial cystitis.
    Soler R, Bruschini H, Truzzi JC, Martins JR, Camara NO, Alves MT, Leite KR, Nader HB, Srougi M, Ortiz V.
    Int Braz J Urol; 2008 Oct 12; 34(4):503-11; discussion 511. PubMed ID: 18778502
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Diagnostic value of urinary CXCL10 as a biomarker for predicting Hunner type interstitial cystitis.
    Niimi A, Igawa Y, Aizawa N, Honma T, Nomiya A, Akiyama Y, Kamei J, Fujimura T, Fukuhara H, Homma Y.
    Neurourol Urodyn; 2018 Mar 12; 37(3):1113-1119. PubMed ID: 29048741
    [Abstract] [Full Text] [Related]

  • 20. Psychological profile of Taiwanese interstitial cystitis patients.
    Fan YH, Lin AT, Wu HM, Hong CJ, Chen KK.
    Int J Urol; 2008 May 12; 15(5):416-8. PubMed ID: 18452458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.